BLT 0.00% 2.6¢ benitec biopharma limited

"biotechs require much more stringent for obvious reasons - to...

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    "biotechs require much more stringent for obvious reasons - to meet guidelines and regulations"

    Hasn't prevented Alnylam from attaining an @ $2billion market cap. Their efficiency and durabilty is questionable to say the least.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.